...
首页> 外文期刊>The Journal of Physiology >The effects of ischaemic preconditioning, diazoxide and 5-hydroxydecanoate on rat heart mitochondrial volume and respiration.
【24h】

The effects of ischaemic preconditioning, diazoxide and 5-hydroxydecanoate on rat heart mitochondrial volume and respiration.

机译:缺血预处理,二氮嗪和5-羟基癸酸酯对大鼠心脏线粒体体积和呼吸的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

Studies with different ATP-sensitive potassium (K(ATP)) channel openers and blockers have implicated opening of mitochondrial K(ATP) (mitoK(ATP)) channels in ischaemic preconditioning (IPC). It would be predicted that this should increase mitochondrial matrix volume and hence respiratory chain activity. Here we confirm this directly using mitochondria rapidly isolated from Langendorff-perfused hearts. Pre-ischaemic matrix volumes for control and IPC hearts (expressed in microl per mg protein +/- S.E.M., n = 6), determined with (3)H(2)O and [(14)C]sucrose, were 0.67 +/- 0.02 and 0.83 +/- 0.04 (P < 0.01), respectively, increasing to 1.01 +/- 0.05 and 1.18 +/- 0.02 following 30 min ischaemia (P < 0.01) and to 1.21 +/- 0.13 and 1.26 +/- 0.25 after 30 min reperfusion. Rates of ADP-stimulated (State 3) and uncoupled 2-oxoglutarate and succinate oxidation increased in parallel with matrix volume until maximum rates were reached at volumes of 1.1 microl ml(-1) or greater. The mitoK(ATP) channel opener, diazoxide (50 microM), caused a similar increase in matrix volume, but with inhibition rather than activation of succinate and 2-oxoglutarate oxidation. Direct addition of diazoxide (50 microM) to isolated mitochondria also inhibited State 3 succinate and 2-oxoglutarate oxidation by 30 %, but not that of palmitoyl carnitine. Unexpectedly, treatment of hearts with the mitoK(ATP) channel blocker 5-hydroxydecanoate (5HD) at 100 or 300 microM, also increased mitochondrial volume and inhibited respiration. In isolated mitochondria, 5HD was rapidly converted to 5HD-CoA by mitochondrial fatty acyl CoA synthetase and acted as a weak substrate or inhibitor of respiration depending on the conditions employed. These data highlight the dangers of using 5HD and diazoxide as specific modulators of mitoK(ATP) channels in the heart.
机译:使用不同的ATP敏感钾(K(ATP))通道开放剂和阻滞剂的研究表明,在缺血预处理(IPC)中打开了线粒体K(ATP)(mitoK(ATP))通道。可以预料,这会增加线粒体基质的体积,从而增加呼吸链的活性。在这里,我们直接使用从Langendorff灌注心脏快速分离的线粒体来证实这一点。用(3)H(2)O和[(14)C]蔗糖测定的对照组和IPC心脏的缺血前基质体积(以微升/ mg蛋白质+/- SEM表示,n = 6)为0.67 + / -缺血后30分钟(P <0.01)分别增加到0.02和0.83 +/- 0.04(P <0.01)和1.01 +/- 0.05和1.18 +/- 0.02和1.21 +/- 0.13和1.26 +/-再灌注30分钟后为0.25。 ADP刺激(状态3)以及未偶联的2-氧戊二酸和琥珀酸氧化的速率与基质体积平行增加,直到在1.1 microl ml(-1)或更大体积时达到最大速率。 mitoK(ATP)通道开放剂二氮嗪(50 microM)引起基质体积的类似增加,但抑制而不是激活琥珀酸和2-氧戊二酸氧化。将二氮嗪(50 microM)直接添加到分离的线粒体中也可以抑制30%琥珀酸和2-氧戊二酸的氧化,但不能抑制棕榈酰肉碱的氧化。出乎意料的是,用100或300 microM的mitoK(ATP)通道阻滞剂5-羟基癸酸酯(5HD)治疗心脏,也会增加线粒体体积并抑制呼吸。在分离的线粒体中,线粒体脂肪酰基辅酶A合成酶将5HD快速转化为5HD-CoA,并根据所使用的条件充当弱的底物或呼吸抑制剂。这些数据突显了使用5HD和二氮嗪作为心脏中mitoK(ATP)通道的特定调节剂的危险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号